AstraZeneca AB v. Wockhardt Bio AG et al > Summary
Court Case Number 1:14-cv-00667
Filing Date May 23, 2014
Court Delaware District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
4AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Charles E. Lipsey
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
Defendant Attorneys
7Wockhardt Bio AG
Attorney Name: Frederick R. Ball
Duane Morris LLP
Wockhardt Bio AG
Attorney Name: Vincent L. Capuano
Duane Morris LLP
Wockhardt Bio AG
Attorney Name: Patrick C. Gallagher
Duane Morris LLP
Wockhardt Bio AG
Attorney Name: Christopher S. Kroon
Duane Morris LLP
Wockhardt Bio AG
Attorney Name: Gary William Lipkin
Wockhardt Bio AG
Attorney Name: Oderah C. Nwaeze
Duane Morris LLP
Wockhardt Bio AG
Attorney Name: Richard William Riley
Duane Morris LLP
Counter Claimant
3Wockhardt Bio AG
Attorney Name: Gary William Lipkin
Wockhardt Bio AG
Attorney Name: Oderah C. Nwaeze
Duane Morris LLP
Wockhardt Bio AG
Attorney Name: Richard William Riley
Duane Morris LLP
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
08628799 | Coated tablet formulation and method | Jan 14, 2014 |
RE044186 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method | Apr 30, 2013 |
07951400 | Coated tablet formulation and method | May 31, 2011 |
06395767 | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method | May 28, 2002 |